Impact of Serum Phosphorus on Hemoglobin: A Literature Review

Fortunata Zirino,Antonella Lipari,Alessia Tigano,Alfio Edoardo Giuffrida,Concetto Sessa,Dario Galeano,Ivana Alessandrello,Roberta Maria Messina,Roberta Pilato,Walter Morale,Vincenzo Calabrese

DOI: https://doi.org/10.69097/41-04-2024-03

2024-08-26

Abstract:Phosphorus is a macroelement found in the body, mostly in the bones as crystals of hydroxyapatite. Higher levels are found in patients affected by chronic kidney disease (CKD). Since the early stage of CKD phosphorous excretion is impaired, but the increase of PTH and FGF23 maintains its level in the normal range. In the last decades, the role of FGF23 in erythropoiesis was studied, and now it is well known for its role in anemia genesis in patients affected by conservative CKD. Both Hyperphosphatemia and anemia are two manifestations of CKD, but many studies showed a direct association between serum phosphorous and anemia. Phosphorus can be considered as the common point of more pathogenetic ways, independent of renal function: the overproduction of FGF23, the worsening of vascular disease, and the toxic impairment of erythropoiesis, including the induction of hemolysis.